Related references
Note: Only part of the references are listed.CDC6 is up-regulated and a poor prognostic signature in glioblastoma multiforme
H. Zhao et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2021)
A molecular signature associated with prolonged survival in glioblastoma patients treated with regorafenib
Alessandra Santangelo et al.
NEURO-ONCOLOGY (2021)
Genome-wide analysis of high-risk primary brain cancer pedigrees identifies PDXDC1 as a candidate brain cancer predisposition gene
Lisa A. Cannon-Albright et al.
NEURO-ONCOLOGY (2021)
Elevated lymphocyte specific protein 1 expression is involved in the regulation of leukocyte migration and immunosuppressive microenvironment in glioulastoma
Jing-Yuan Cao et al.
AGING-US (2020)
IFI30 Is a Novel Immune-Related Target with Predicting Value of Prognosis and Treatment Response in Glioblastoma
Chen Zhu et al.
ONCOTARGETS AND THERAPY (2020)
Identity and lineage fate of proteolipid protein 1 gene (Plp1)-expressing cells in the embryonic murine spinal cord
Shujing Guo et al.
DEVELOPMENTAL DYNAMICS (2020)
Single-Cell Atlas Reveals Complexity of the Immunosuppressive Microenvironment of Initial and Recurrent Glioblastoma
Weilun Fu et al.
FRONTIERS IN IMMUNOLOGY (2020)
PD-L1 Inhibitor Regulates the miR-33a-5p/PTEN Signaling Pathway and Can Be Targeted to Sensitize Glioblastomas to Radiation
Wenzheng Xia et al.
FRONTIERS IN ONCOLOGY (2020)
RPP30, a transcriptional regulator, is a potential pathogenic factor in glioblastoma
Guanzhang Li et al.
AGING-US (2020)
Current advances in PD-1/PD-L1 axis-related tumour-infiltrating immune cells and therapeutic regimens in glioblastoma
Chang Shu et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
Functional analysis of CX3CR1 in human induced pluripotent stem (iPS) cell-derived microglia-like cells
Nobuhito Murai et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2020)
Both p53 codon 72 Arg/Arg and pro/Arg genotypes in glioblastoma multiforme are associated with a better prognosis in bevacizumab treatment
Chiung-Chyi Shen et al.
BMC CANCER (2020)
Genetic driver mutations introduced in identical cell-of-origin in murine glioblastoma reveal distinct immune landscapes but similar response to checkpoint blockade
Zhihong Chen et al.
GLIA (2020)
Long non-coding RNA LINC01426 facilitates glioblastoma progression via sponging miR-345-3p and upregulation of VAMP8
Jingwei Cao et al.
CANCER CELL INTERNATIONAL (2020)
AKT Inhibitor SC66 Inhibits Proliferation and Induces Apoptosis in Human Glioblastoma Through Down-Regulating AKT/β-Catenin Pathway
Lun Gao et al.
FRONTIERS IN PHARMACOLOGY (2020)
Beyond IDH-Mutation: Emerging Molecular Diagnostic and Prognostic Features in Adult Diffuse Gliomas
Kanish Mirchia et al.
CANCERS (2020)
PD-L1 Expression in Glioblastoma, the Clinical and Prognostic Significance: A Systematic Literature Review and Meta-Analysis
Chengcheng Hao et al.
FRONTIERS IN ONCOLOGY (2020)
Real-World Evidence in Glioblastoma: Stupp's Regimen After a Decade
Radek Lakomy et al.
FRONTIERS IN ONCOLOGY (2020)
Gene regulation network analysis reveals core genes associated with survival in glioblastoma multiforme
Lan Jiang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
RBPJ contributes to the malignancy of glioblastoma and induction of proneural-mesenchymal transition via IL-6-STAT3 pathway
Guangtao Zhang et al.
CANCER SCIENCE (2020)
Epigenetic age acceleration and clinical outcomes in gliomas
Chunlei Zheng et al.
PLOS ONE (2020)
Comprehensive Transcriptomic Analysis and Experimental Validation Identify lncRNA HOXA-AS2/miR-184/COL6A2 as the Critical ceRNA Regulation Involved in Low-Grade Glioma Recurrence
Peng-Yu Chen et al.
ONCOTARGETS AND THERAPY (2020)
Single-cell RNA-seq reveals that glioblastoma recapitulates a normal neurodevelopmental hierarchy
Charles P. Couturier et al.
NATURE COMMUNICATIONS (2020)
RELL1, a novel oncogene, accelerates tumor progression and regulates immune infiltrates in glioma
Xiaohong Jin et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
IFI30 expression is an independent unfavourable prognostic factor in glioma
Xiu Liu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Generation of oligodendrocytes and establishment of an all-human myelinating platform from human pluripotent stem cells
Juan Antonio Garcia-Leon et al.
NATURE PROTOCOLS (2020)
The neural stem-cell marker CD24 is specifically upregulated in IDH-mutant glioma
Patricia D. B. Tiburcio et al.
TRANSLATIONAL ONCOLOGY (2020)
A facile and scalable in production non-viral gene engineered mesenchymal stem cells for effective suppression of temozolomide-resistant (TMZR) glioblastoma growth
Geraldine Xue En Tu et al.
STEM CELL RESEARCH & THERAPY (2020)
T cell receptor repertoire as a prognosis marker for heat shock protein peptide complex-96 vaccine trial against newly diagnosed glioblastoma
Yang Zhang et al.
ONCOIMMUNOLOGY (2020)
Human Interleukin-34 facilitates microglia-like cell differentiation and persistent HIV-1 infection in humanized mice
Saumi Mathews et al.
MOLECULAR NEURODEGENERATION (2019)
Molecular responses to immune checkpoint blockade in glioblastoma
Hirotaka Ito et al.
NATURE MEDICINE (2019)
The promising novel biomarkers and candidate small molecule drugs in lower-grade glioma: Evidence from bioinformatics analysis of high-throughput data
Bo Zhang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Glioblastoma Therapy in the Age of Molecular Medicine
Luiz Henrique Medeiros Geraldo et al.
TRENDS IN CANCER (2019)
Comparative analysis of histologically classified oligodendrogliomas reveals characteristic molecular differences between subgroups
Chris Lauber et al.
BMC CANCER (2018)
Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq
Mariella G. Filbin et al.
SCIENCE (2018)
Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014
Quinn T. Ostrom et al.
JAMA ONCOLOGY (2018)
WINDOW consortium: A path towards increased therapy efficacy against glioblastoma
Kulsoom U. Abdul et al.
DRUG RESISTANCE UPDATES (2018)
Immune microenvironment of gliomas
Anna Gieryng et al.
LABORATORY INVESTIGATION (2017)
The Microenvironmental Landscape of Brain Tumors
Daniela F. Quail et al.
CANCER CELL (2017)
Tumor infiltrating immune cells in gliomas and meningiomas
Patricia Domingues et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Structural Insights into the Niemann-Pick C1 (NPC1)-Mediated Cholesterol Transfer and Ebola Infection
Xin Gong et al.
CELL (2016)
Clues to the mechanism of cholesterol transfer from the structure of NPC1 middle lumenal domain bound to NPC2
Xiaochun Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Pleiotropic Associations of Risk Variants Identified for Other Cancers With Lung Cancer Risk: The PAGE and TRICL Consortia
S. Lani Park et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Common Variation in Genes Related to Innate Immunity and Risk of Adult Glioma
Preetha Rajaraman et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
NPC2 facilitates bidirectional transfer of cholesterol between NPC1 and lipid bilayers, a step in cholesterol egress from lysosomes
Rodney E. Infante et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma
Ilhem Diboun et al.
BMC GENOMICS (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Large-scale identification of secreted and membrane-associated gene products using DNA microarrays
M Diehn et al.
NATURE GENETICS (2000)
Share Paper
